Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic Profiles

被引:22
|
作者
St Jean, David J., Jr. [1 ]
Ashton, Kate S. [1 ]
Bartberger, Michael D. [2 ]
Chen, Jie [4 ]
Chmait, Samer [2 ]
Cupples, Rod [3 ]
Galbreath, Elizabeth [5 ]
Helmering, Joan [3 ]
Hong, Fang-Tsao [1 ]
Jordan, Steven R. [2 ]
Liu, Longbin [1 ]
Kunz, Roxanne K. [1 ]
Michelsen, Klaus [2 ]
Nishimura, Nobuko [1 ]
Pennington, Lewis D. [1 ]
Poon, Steve F. [1 ]
Reid, Darren [6 ]
Sivits, Glenn [3 ]
Stec, Markian M. [1 ]
Tadesse, Seifu [1 ]
Tamayo, Nuria [1 ]
Van, Gwyneth [5 ]
Yang, Kevin C. [1 ]
Zhang, Jiandong [2 ]
Norman, Mark H. [1 ]
Fotsch, Christopher [1 ]
Lloyd, David J. [3 ]
Hale, Clarence [3 ]
机构
[1] Amgen Inc, Dept Therapeut Discovery Med Chem, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Therapeut Discovery Mol Struct & Characteriz, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA
[5] Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA
[6] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA
关键词
DIABETES THERAPY; ACTIVATORS;
D O I
10.1021/jm4016747
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the previous report, we described the discovery and optimization of novel small molecule disruptors of the GK-GKRP interaction culminating in the identification of 1 (AMG-1694). Although this analogue possessed excellent in vitro potency and was a useful tool compound in initial proof-of-concept experiments, high metabolic turnover limited its advancement. Guided by a combination of metabolite 27 identification and structure-based design, we have successfully discovered a potent and metabolically stable GK-GKRP disruptor (27, AMG-3969). When administered to db/db mice, this compound demonstrated a robust pharmacodynamic response (GK translocation) as well as statistically significant dose-dependent reductions in fed blood glucose levels.
引用
收藏
页码:325 / 338
页数:14
相关论文
共 23 条
  • [1] Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 4. Exploration of a Novel Binding Pocket
    Hong, Fang-Tsao
    Norman, Mark H.
    Ashton, Kate S.
    Bartberger, Michael D.
    Chen, Jie
    Chmait, Samer
    Cupples, Rod
    Fotsch, Christopher
    Jordan, Steven R.
    Lloyd, David J.
    Sivits, Glenn
    Tadesse, Seifu
    Hale, Clarence
    St Jean, David J., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (14) : 5949 - 5964
  • [2] Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept
    Ashton, Kate S.
    Andrews, Kristin L.
    Bryan, Marion C.
    Chen, Jie
    Chen, Kui
    Chen, Michelle
    Chmait, Samer
    Croghan, Michael
    Cupples, Rod
    Fotsch, Christopher
    Helmering, Joan
    Jordan, Steve R.
    Kurzeja, Robert J. M.
    Michelsen, Klaus
    Pennington, Lewis D.
    Poon, Steve F.
    Sivits, Glenn
    Van, Gwyneth
    Vonderfecht, Steve L.
    Wahl, Robert C.
    Zhang, Jiandong
    Lloyd, David J.
    Hale, Clarence
    St Jean, David J., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (02) : 309 - 324
  • [3] Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis
    Tamayo, Nuria A.
    Norman, Mark H.
    Bartberger, Michael D.
    Hong, Fang-Tsao
    Bo, Yunxin
    Liu, Longbin
    Nishimura, Nobuko
    Yang, Kevin C.
    Tadesse, Seifu
    Fotsch, Christopher
    Chen, Jie
    Chmait, Samer
    Cupples, Rod
    Hale, Clarence
    Jordan, Steven R.
    Lloyd, David J.
    Sivits, Glenn
    Van, Gwyneth
    Jean, David J. St., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4462 - 4482
  • [4] Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept (vol 57, pg 309, 2014)
    Ashton, Kate S.
    Andrews, Kristin L.
    Bryan, Marian C.
    Chen, Jie
    Chen, Kui
    Chen, Michelle
    Chmait, Samer
    Croghan, Michael
    Cupples, Rod
    Fotsch, Christopher
    Helmering, Joan
    Jordan, Steve R.
    Kurzeja, Robert J. M.
    Michelsen, Klaus
    Pennington, Lewis D.
    Poon, Steve F.
    Sivits, Glenn
    Van, Gwyneth
    Vonderfecht, Steve L.
    Wahl, Robert C.
    Zhang, Jiandong
    Lloyd, David J.
    Hale, Clarence
    St. Jean, David J., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2820 - 2820
  • [5] Small Molecule Disruptors of the Glucokinase Glucokinase Regulatory Protein Interaction: 3. Structure Activity Relationships within the Aryl Carbinol Region of the N-Arylsulfonamido-N'-arylpiperazine Series
    Nishimura, Nobuko
    Norman, Mark H.
    Liu, Longbin
    Yang, Kevin C.
    Ashton, Kate S.
    Bartberger, Michael D.
    Chmait, Samer
    Chen, Jie
    Cupples, Rod
    Fotsch, Christopher
    Helmering, Joan
    Jordan, Steven R.
    Kunz, Roxanne K.
    Pennington, Lewis D.
    Poon, Steve F.
    Siegmund, Aaron
    Sivits, Glenn
    Lloyd, David J.
    Hale, Clarence
    St Jean, David J., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (07) : 3094 - 3116
  • [6] Structure-Based Drug Design: Identification of Glucokinase Activators from Natural Compounds for the Treatment of Type 2 Diabetes
    Malini, Manokaran
    Thilagavathi, Ramasamy
    Singh, Sanjeev Kumar
    Pravin, Arun
    Selvam, Chelliah
    CHEMISTRYSELECT, 2023, 8 (15):
  • [7] Improved structure-based drug design with one million small molecule crystal structures
    Kuhn, Bernd
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [8] Identification of small-molecule glucokinase activator for type-2-diabetes treatment: a structure-based virtual screening approach
    Malini, Manokaran
    Thilagavathi, Ramasamy
    Vennila, Jannet
    Malgija, Beutline
    Praveena, Gandhi
    Selvam, Chelliah
    MOLECULAR SIMULATION, 2023, 49 (17) : 1596 - 1613
  • [9] Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands
    Cummings, Maxwell D.
    Sekharan, Sivakumar
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (15) : 6843 - 6853
  • [10] Identification of small-molecule inhibitors of the steroidogenic acute regulatory protein (STARD1) by structure-based design
    Akula, Nagaraju
    Midzak, Andrew
    Lecanu, Laurent
    Papadopoulos, Vassilios
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4139 - 4143